help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on May 15, 2009, doi:10.1164/rccm.200809-1484OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200809-1484OCv1
180/3/265    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Schelegle, E. S.
Right arrow Articles by Allen, R. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schelegle, E. S.
Right arrow Articles by Allen, R. P.
American Journal of Respiratory and Critical Care Medicine Vol 180. pp. 265-272, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200809-1484OC


Original Article

6.6-Hour Inhalation of Ozone Concentrations from 60 to 87 Parts per Billion in Healthy Humans

Edward S. Schelegle1, Christopher A. Morales1, William F. Walby1, Susan Marion2 and Roblee P. Allen3

1 Department of Anatomy, Physiology, and Cell Biology, University of California Davis School of Veterinary Medicine, Davis; 2 California National Primate Research Center, University of California Davis, Davis; and 3 Department of Internal Medicine, University of California Davis Medical Center, Sacramento, California

Correspondence and requests for reprints should be addressed to Edward S. Schelegle, Ph.D., Department of Anatomy, Physiology, and Cell Biology, University of California Davis, 1 Shields Avenue, Davis, CA 95616. E-mail: esschelegle{at}ucdavis.edu

Rationale: Identification of the minimal ozone (O3) concentration and/or dose that induces measurable lung function decrements in humans is considered in the risk assessment leading to establishing an appropriate National Ambient Air Quality Standard for O3 that protects public health.

Objectives: To identify and/or predict the minimal mean O3 concentration that produces a decrement in FEV1 and symptoms in healthy individuals completing 6.6-hour exposure protocols.

Methods: Pulmonary function and subjective symptoms were measured in 31 healthy adults (18–25 yr, male and female, nonsmokers) who completed five 6.6-hour chamber exposures: filtered air and four variable hourly patterns with mean O3 concentrations of 60, 70, 80, and 87 parts per billion (ppb).

Measurements and Main Results: Compared with filtered air, statistically significant decrements in FEV1 and increases in total subjective symptoms scores (P < 0.05) were measured after exposure to mean concentrations of 70, 80, and 87 ppb O3. The mean percent change in FEV1 (±standard error) at the end of each protocol was 0.80 ± 0.90, –2.72 ± 1.48, –5.34 ± 1.42, –7.02 ± 1.60, and –11.42 ± 2.20% for exposure to filtered air and 60, 70, 80, and 87 ppb O3, respectively.

Conclusions: Inhalation of 70 ppb O3 for 6.6 hours, a concentration below the current 8-hour National Ambient Air Quality Standard of 75 ppb, is sufficient to induce statistically significant decrements in FEV1 in healthy young adults.

Key Words: ozone • clinical study • exposure assessment • human


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
The acute inhalation of ambient concentrations of ozone induces several health effects including airway irritation and inflammation, decrements in pulmonary function, and symptoms of respiratory discomfort.

What This Study Adds to the Field
This study identifies 70 ppb as the mean concentration of ozone averaged over 6.6 hours that results in a statistically significant decrement in FEV1 and presents an empirically validated model that predicts the onset of pulmonary responses induced by any combination of ozone concentration, minute ventilation, and exposure duration.

 

Related articles in AJRCCM:

Acute Effects of Exposure to Ozone in Humans: How Low Can Levels Be and Still Produce Effects?
James S. Brown
AJRCCM 2009 180: 200-201. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
J. S. Brown
Acute Effects of Exposure to Ozone in Humans: How Low Can Levels Be and Still Produce Effects?
Am. J. Respir. Crit. Care Med., August 1, 2009; 180(3): 200 - 201.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  Tobacco